Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.

The heavy chains of mAbs, but not the light chains, showed a significant trend ( P =0.012) to greater divergence from germline with increased time between infection and peripheral blood mononuclear cell (PBMC) collection ( Fig. 8e ).

also in 6,185 other papers